Centene Dirección
Dirección controles de criterios 1/4
El CEO de Centene's es Sarah London , nombrado en Mar 2022, tiene una permanencia de 2.08 años. compensación anual total es $18.56M, compuesta por 7.5% salario y 92.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.018% de las acciones de la empresa, por valor de $7.31M. La antigüedad media del equipo directivo y de la junta directiva es de 2.5 años y 2.4 años, respectivamente.
Información clave
Sarah London
Chief Executive Officer (CEO)
US$18.6m
Compensación total
Porcentaje del salario del CEO | 7.5% |
Permanencia del CEO | 2.1yrs |
Participación del CEO | 0.02% |
Permanencia media de la dirección | 2.5yrs |
Promedio de permanencia en la Junta Directiva | 2.4yrs |
Actualizaciones recientes de la dirección
Recent updates
These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well
Apr 26Centene Corporation Still An Opportunity With An A-Grade Valuation
Mar 31If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Mar 15Market Still Lacking Some Conviction On Centene Corporation (NYSE:CNC)
Feb 08Centene: Stay Defensive Amid Economic Uncertainty With This Low-Beta Bargain
Jan 22Is Centene (NYSE:CNC) Using Too Much Debt?
Jan 21Centene: Overlooked Healthcare Giant
Nov 21Does Centene (NYSE:CNC) Deserve A Spot On Your Watchlist?
Nov 10Centene: Solid Performance With Positive Outlook, But Limited Upside Potential
Oct 26These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well
Oct 22Decoding Centene: Why I Think It's Undervalued
Oct 10If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Jul 31Centene: Results Impress But Buyers Aren't Swarming Yet
Jul 27Centene (NYSE:CNC) Has A Pretty Healthy Balance Sheet
Jul 12Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly
Apr 10Centene Non-GAAP EPS of $0.86 beats by $0.02, revenue of $35.56B beats by $190M
Feb 07With EPS Growth And More, Centene (NYSE:CNC) Makes An Interesting Case
Jan 27Centene (NYSE:CNC) Seems To Use Debt Rather Sparingly
Dec 27Centene: Once Again, With Quality, Now A 'Buy'
Dec 23Centene appoints new leadership; Ken Fasola President of Centene, Dave Thomas CEO of Medicaid
Dec 14An Intrinsic Calculation For Centene Corporation (NYSE:CNC) Suggests It's 50% Undervalued
Nov 11Is Now The Time To Put Centene (NYSE:CNC) On Your Watchlist?
Oct 26Centene Q3 2022 Earnings Preview
Oct 24Centene: Future Growth Will Exceed Market Expectations
Oct 14Centene: A Chaos Stock
Sep 28Does Centene (NYSE:CNC) Have A Healthy Balance Sheet?
Sep 20Centene falls 7%, most since April 2021, on surging volume
Sep 14If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Jul 28Centene Q2 2022 Earnings Preview
Jul 25Centene Keeps Overdelivering - But Is Expensive
Jul 11Is Centene (NYSE:CNC) Using Too Much Debt?
Jun 16Centene: Solid Q122 Earnings For Health Insurer Helps Make Buy/Hold Case
Apr 28Centene Has Overdelivered - It Is Time For A 'Hold'
Mar 24We Think Centene (NYSE:CNC) Can Stay On Top Of Its Debt
Mar 14Centene: Finally Gets Respect And Is Poised To Profit
Dec 31Is Centene (NYSE:CNC) A Risky Investment?
Dec 13Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Mar 31 2024 | n/a | n/a | US$3b |
Dec 31 2023 | US$19m | US$1m | US$3b |
Sep 30 2023 | n/a | n/a | US$2b |
Jun 30 2023 | n/a | n/a | US$3b |
Mar 31 2023 | n/a | n/a | US$1b |
Dec 31 2022 | US$13m | US$1m | US$1b |
Sep 30 2022 | n/a | n/a | US$2b |
Jun 30 2022 | n/a | n/a | US$2b |
Mar 31 2022 | n/a | n/a | US$1b |
Dec 31 2021 | US$15m | US$978k | US$1b |
Compensación vs. Mercado: La compensación total de Sarah($USD18.56M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD13.52M).
Compensación vs. Ingresos: La compensación de Sarah ha aumentado más de un 20% en el último año.
CEO
Sarah London (42 yo)
2.1yrs
Permanencia
US$18,556,966
Compensación
Ms. Sarah M. London has been the Chief Executive Officer of Centene Corporation since March 21, 2022 and serves as its Director since September 2021. She served as President of Health Care Enterprises and...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
CEO & Director | 2.1yrs | US$18.56m | 0.018% $ 7.2m | |
President | 1.3yrs | US$10.62m | 0.010% $ 4.1m | |
Executive VP & CFO | 2.9yrs | US$9.91m | 0.036% $ 14.3m | |
Executive VP | 4.2yrs | US$4.84m | 0.017% $ 6.9m | |
CEO of Markets & Medicaid | 5.3yrs | US$6.20m | 0.0089% $ 3.5m | |
Chief Operating Officer | less than a year | sin datos | sin datos | |
Senior VP | 3yrs | sin datos | 0.0053% $ 2.1m | |
Chief Information Officer | 1.3yrs | sin datos | sin datos | |
Senior Vice President of Investor Relations | 4yrs | sin datos | sin datos | |
Chief Risk | 1.6yrs | sin datos | sin datos | |
Senior VP & Chief Communications Officer | less than a year | sin datos | sin datos | |
Senior VP & Chief Marketing Officer | 2.9yrs | sin datos | sin datos |
2.5yrs
Permanencia media
55.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de CNC se considera experimentado (2.5 años antigüedad media).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
CEO & Director | 2.6yrs | US$18.56m | 0.018% $ 7.2m | |
Independent Director | 1.4yrs | US$324.98k | 0.00026% $ 103.2k | |
Independent Chairman | 18yrs | US$537.45k | 0.032% $ 12.7m | |
Independent Director | 2.3yrs | US$369.98k | 0.0037% $ 1.5m | |
Lead Independent Director | 4.3yrs | US$474.98k | 0.0042% $ 1.7m | |
Independent Director | 2.3yrs | US$372.48k | 0.0014% $ 555.7k | |
Independent Director | 2.3yrs | US$349.98k | 0.0047% $ 1.9m | |
Director | 2.3yrs | US$1.25m | 0.083% $ 32.8m | |
Independent Director | 6.2yrs | US$344.98k | 0.0035% $ 1.4m | |
Independent Director | 4.5yrs | US$299.98k | 0.0016% $ 631.1k |
2.4yrs
Permanencia media
64yo
Promedio de edad
Junta con experiencia: La junta directiva de CNC no se considera experimentada (2.4 años de permanencia promedio), lo que sugiere una nueva junta directiva.